caution larry

Hi, I’m Kim! This site provides a little insight to my journey of being diagnosised with Remitting Relapsing Multiple Sclerosis on October 26th 2004. I review books and documentaries, post MS-related news, and share my photos.

Subscribe (RSS)

no larry

My bloglines

Archives

Current

November 2004
December 2004
January 2005
February 2005
March 2005
April 2005
May 2005
June 2005
July 2005
August 2005
September 2005
October 2005
November 2005
December 2005
January 2006
February 2006
March 2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
January 2008
February 2008
March 2008
April 2008
May 2008
June 2008
July 2008
August 2008
September 2008
October 2008
November 2008
December 2008
January 2009
February 2009
March 2009
April 2009
May 2009
June 2009
July 2009
August 2009
September 2009
October 2009
November 2009
December 2009
January 2010
February 2010
March 2010
May 2010
June 2010
July 2010
September 2010
November 2011

 

Monday, August 27, 2007
Omega 3, stress, and DNA vaccine
 
Omega 3 Fatty Acids does help MS

More updated news confirming that taking Omega Fatty acids is of benefit. "Health care practitioners often recommend eating fish at least twice per week because fish contain high levels of omega-3 fatty acids. Omega-3 fatty acids contain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are known to affect key blood proteins (matrix metalloproteinase-9; MMP-9) and are produced by the immune cells of individuals with MS. A new study evaluating the effects of omega-3 on MMP-9 in patients with MS suggests that the intake of fish oil, containing omega-3 fatty acids, may have potential benefit in MS by decreasing MMP-9 levels. The purpose of the study was to evaluate the effect of omega-3 fatty acids on ten patients with MS. Ten MS participants received 9.6 grams of fish oil/day in an open-label study. An in vitro study using immune cells from healthy subjects was also conducted simultaneously to evaluate concentration effects of EPA and DHA on MMP-9 levels and activity. The researchers found there was a 58 percent decrease in MMP-9 levels secreted from immune cells of MS volunteers after three months of fish oil supplementation compared to baseline levels. At three months, both EPA and DHA levels were significantly increased in red blood cell membranes. The in vitro study showed a significant decrease in MMP-9 levels and activity for EPA and DHA. Omega-3 fatty acids decrease both MMP-9 levels and activity and may act as immune-modulators that could benefit MS patients."

What does stress do to someone with MS?

This report says that stress does impact us in a bad way... not surprising right? "Stress appeared to elevate levels of protein cytokine called interleukin-6 (IL-6), which led to increased severity of multiple sclerosis-like illnesses in the mice. Cytokines are pro-inflammatory proteins that regulate immunity and inflammatory functions. The researchers also found that giving the mice IL-6 neutralising antibody treatments during stressful events prevented the stress-related worsening of the MS-like diseases. "People exposed to chronic social conflict experience high levels of stress and consequent dysregulation of the immune system, thereby increasing vulnerability to infectious and autoimmune diseases," lead researcher Mary Meagher said. "

DNA vaccine BHT-3009

Interesting... I had seen postings about this drug in the past couple of years, but nothing about calling it a vaccine. Regardless, it's moving ahead in trial world and thats a good thing :) "Magnetic resonance imaging (MRI) and other safety evaluations were performed at the beginning of the study, and again after five, nine, 13, 26, 38 and 50 weeks. "BHT-3009 was safe and well tolerated, provided favorable trends on brain MRI and produced beneficial antigen-specific immune changes," the authors write. These changes included a reduction in the number of cytokine-producing CD4+ T cells (a type of white blood cell) specifically targeting myelin proteins. This reduction was found in the blood as well as in the cerebrospinal fluid of three patients who voluntarily underwent lumbar puncture after completing the course of BHT-3009. Atorvastatin did not appear to provide additional benefit. "There were no increases in clinical relapses, disability, drug-associated laboratory abnormalities, adverse events or the number and volume of contrast-enhancing [visible on MRI] lesions on brain MRI with BHT-3009 treatment compared with placebo," the authors write. "In fact, there was a trend toward a decrease in the number and volume of contrast-enhancing lesions in the brain in patients treated with BHT-3009 compared with placebo." Based on these results, a phase 2b trial--a randomized clinical trial in approximately 290 patients--of BHT-3009 is already under way. "If successful in MS, antigen-specific DNA vaccines can be developed for prevention or treatment of related diseases, such as type 1 diabetes mellitus, systemic lupus erythematosus, rheumatoid arthritis and myasthenia gravis," the authors conclude. "